SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update

Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 ...
Devdiscourse

India Moving Towards Era of Precision Medicine Driven by Genomics and AI: Dr Jitendra Singh

Dr Singh said India holds a unique advantage in genomic research due to its large and diverse population with more than 4,000–5,000 distinct communities.
Daily Excelsior

Future belongs to genomics driven ‘personalised medical prescriptions’: Dr Jitendra

Union Minister of State (Independent Charge) for Science & Technology, Earth Sciences and Minister of State in PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space Dr. Jitendra Singh ...

Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation

HAMBURG, DE / ACCESS Newswire / March 19, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced that its partner Bristol Myers Squibb (BMS) has initiated a Phase 1 clinical study ...

Evotec SE: Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation

Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of advanced clear cell renal cell carcinoma, the most common form of kidney cancerTransformative moment in ...
Frontiers

Advances in Multi-Modal Artificial Intelligence for Oncology

Since its inception, artificial intelligence (AI) has been developed to mimic the adaptation and self-organization of living organisms or biological ...
Frontiers

Transformer-Enabled Multi-Omics Interpretation: LLM Pipelines for Cross-Dataset Annotation and Uncertainty-Aware Integration

You will be redirected to our submission process. Multi-omics studies now span genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiomics, and spatial and single-cell modalities, ...